February 21, 2022 – Of the various adult medicine specialties, physicians specializing in endocrinology and gastroenterology had the highest rates of telehealth adoption during the COVID-19 pandemic, according to a new report. Released by Doximity in partnership with CareJourney, the report analyzes survey responses from physicians who use Doximity’s telemedicine platform and bill Medicare. Approximately 185,000 US physicians billed Medicare telehealth claims from January 2020 to June 2021, of which 45 percent used Doximity’s platform.
Author: Praveen Suthrum
Las Vegas—In the United States, clinical trials of treatments for inflammatory bowel disease enroll a smaller proportion of Black and Hispanic patients than white or Asian patients, at rates that do not track with the prevalence of diseases in these groups, according to research presented at the 2021 annual meeting of the American College of Gastroenterology. The finding could mean that any new treatments that emerge from such clinical trials are not generalizable to all population groups in this country, according to the authors, whose research was cited by the ACG as noteworthy (oral presentation 69).
DUBLIN, Feb. 22, 2022 /PRNewswire/ — Medtronic plc ( NYSE:MDT), a global leader in healthcare technology, today announced it received approval from the U.S. Food and Drug Administration (FDA) for InterStim X™ ― the next generation of the InterStim™ portfolio’s recharge-free device – and it is available immediately. InterStim systems are the standard of care in advanced therapy options, and the most personalized system, to deliver sacral neuromodulation (SNM) therapy. Now the only SNM system backed by 90+ clinical studies, 1,000+ clinical articles, 350,000 patients treated and 25 years of experience, also offers patients a decade or more of treatment with either the new…
Dr. Michael Weinstein of Capital Digestive Care talks to Dr. Costas Kefalas from Akron Digestive Disease Consultants about his work as the president of the GI Quality Improvement Consortium (GIQuIc), a benchmarking registry that tracks quality measures such as cecal intubation rates, withdrawal times and adenoma detection rates. Hear about the path Dr. Kefalas took to independent GI, his role in co-founding the Ohio Gastroenterology Society, and how drumming in an acoustic Greek band called Aegean Odyssey is his way to release stress.
Big Pharma, private equity and private payers are some of the forces Gabriel Ionescu, MD, sees as decision makers in the future of healthcare. Dr. Ionescu is a gastroenterologist at Wyckoff Heights Medical Center in New York City. He joined Becker’s ASC Review to discuss his predictions.
Health industry officials hope a palette of possible fixes will help save a disputed Medicare pilot program that faces overhaul or elimination by the Biden administration as early as this week. The suggested changes range from limiting the role of private equity and health insurers in the program to revamping how spending targets for care are set.
Medscape surveyed more than 13,000 physicians and the report explores physicians’ happiness with their personal life and professional work.
Gastroenterology has been characterized by consolidation and the growth of management service organizations and megagroups. “Megagroups” are defined as practices with 15 or more gastroenterologists, according to a report jointly published by consulting firm Fraser Healthcare and pharma research firm Spherix Global Insights. Megagroup gastroenterologists can overlap as members of a management service organization or health system, but some are still independent.
Let’s start with some numbers (As compared to the same period of 2020 and the previous quarter Q3, 2021): ◘ Total revenue was $473.8 million, an increase of 2 percent (compare that to $466.3 million in Q4, 2020 and $456.4 million in Q3, 2021) ◘ Screening revenue was $277.7 million, an increase of 11 percent (compare that to $249.7 million in Q4, 2020 and $280.4 million in Q3, 2021)
Silver Spring, Md, Feb. 23, 2022 (GLOBE NEWSWIRE) — Capital Digestive Care, the largest private gastroenterology practice in the Mid-Atlantic region, announced it has signed a transaction with Gastroenterology, Ltd. of Virginia Beach (GLTD), a premier gastroenterology practice in Southeastern Virginia. The deal marks Capital Digestive Care’s second major partnership in Virginia over the past year after Gastrointestinal & Liver Specialists of Tidewater (GLST) joined the group in 2021. With the addition of GLTD, Capital Digestive Care will add two office locations and a state-of-the-art endoscopy center, bringing the number of GI specialists serving the region to more than 140.